{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:30:00Z","timestamp":1769877000019,"version":"3.49.0"},"reference-count":17,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Neurodegener. Dis. Manag."],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.2217\/nmt.15.42","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T17:39:57Z","timestamp":1446226797000},"page":"399-402","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Progressive Multifocal Leukoencephalopathy Associated to Natalizumab Extended Dosing Regimen"],"prefix":"10.1080","volume":"5","author":[{"given":"Jos\u00e9 Vicente","family":"Herv\u00e1s-Garc\u00eda","sequence":"first","affiliation":[{"name":"Department of Neurosciences Multiple Sclerosis Unit Germans Trias i Pujol Hospital. C\/Canyet s\/n 08916\rBadalona\rSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Presas-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Department of Neurosciences Multiple Sclerosis Unit Germans Trias i Pujol Hospital. C\/Canyet s\/n 08916\rBadalona\rSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ane Miren","family":"Crespo-Cuevas","sequence":"additional","affiliation":[{"name":"Department of Neurosciences Multiple Sclerosis Unit Germans Trias i Pujol Hospital. C\/Canyet s\/n 08916\rBadalona\rSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Canento","sequence":"additional","affiliation":[{"name":"Department of Neurosciences Multiple Sclerosis Unit Germans Trias i Pujol Hospital. C\/Canyet s\/n 08916\rBadalona\rSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Lozano-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Neurosciences Multiple Sclerosis Unit Germans Trias i Pujol Hospital. C\/Canyet s\/n 08916\rBadalona\rSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Massuet-Vilamaj\u00f3","sequence":"additional","affiliation":[{"name":"Department of Neurosciences Multiple Sclerosis Unit Germans Trias i Pujol Hospital. C\/Canyet s\/n 08916\rBadalona\rSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ramo-Tello","sequence":"additional","affiliation":[{"name":"Department of Neurosciences Multiple Sclerosis Unit Germans Trias i Pujol Hospital. C\/Canyet s\/n 08916\rBadalona\rSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044397"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24286"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756285614540224"},{"key":"e_1_3_2_6_1","volume-title":"65th Annual Meeting of the American Academy of Neurology","author":"Cree B","year":"2013","unstructured":"Cree B , De S\u00e8zeJ, FoxRet al. Natalizumab effects during a 6-month dose interruption: relationship of pharmacokinetic (PK), pharmacodynamic (PD), and MRI measurements . Presented at : 65th Annual Meeting of the American Academy of Neurology . San Diego, CA, USA, 16\u201322 March 2013 ."},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821e7c8a"},{"key":"e_1_3_2_8_1","volume-title":"64th Annual Meeting of the American Academy of Neurology","author":"Cree B","year":"2012","unstructured":"Cree B , De S\u00e8zeJ, FoxRet al. RESTORE Study: effects of a 24-week natalizumab treatment interruption on immune parameters and multiple sclerosis magnetic resonance imaging disease activity . Presented at : 64th Annual Meeting of the American Academy of Neurology . New Orleans, LA, USA, 21\u201328 April 2012 ."},{"key":"e_1_3_2_9_1","volume-title":"4th Cooperative Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and 17th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)","author":"Fox R","year":"2012","unstructured":"Fox R , CreeB, De S\u00e8zeJet al. RESTORE study: effects of natalizumab interruption on multiple sclerosis disease activity . Presented at : 4th Cooperative Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and 17th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) . San Diego, CA, USA, 30 May 2012 ."},{"key":"e_1_3_2_10_1","volume-title":"5th Joint triennial congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis","author":"Cordioli C","year":"2011","unstructured":"Cordioli C , RasiaS, de RossiNet al. Safety and efficacy of natalizumab infusions every eight weeks after a 24 month period of monthly infusions in multiple sclerosis patients . Presented at : 5th Joint triennial congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis . Amsterdam, The Netherlands, 19\u201322 October 2011 ."},{"key":"e_1_3_2_11_1","volume-title":"2014 Joint ACTRIMS-ECTRIMS Meeting","author":"Herbert J","year":"2014","unstructured":"Herbert J , RyersonL, KisterIet al. Establishment of a global registry for multiple sclerosis patients on extended dose natalizumab dosing . Presented at : 2014 Joint ACTRIMS-ECTRIMS Meeting . Boston, MA, USA, September 2014 ."},{"key":"e_1_3_2_12_1","volume-title":"66th Annual Meeting of the American Academy of Neurology","author":"Herbert J","year":"2014","unstructured":"Herbert J , RyersonLZ, TornatoreCet al. Multicenter retrospective study of extended dosing of natalizumab in multiple sclerosis: a strategy for mitigating risk of progressive multifocal leukoencephalopathy while maintaining efficacy? Presented at : 66th Annual Meeting of the American Academy of Neurology . Philadelphia, PA, USA, 26 April\u20133 May 2014 ."},{"key":"e_1_3_2_13_1","volume-title":"67th Annual Meeting of the American Academy of Neurology","author":"Ryerson LZ","year":"2015","unstructured":"Ryerson LZ , HerbertJ, FoleyJet al. Safety and efficacy of extended dose natalizumab in multiple sclerosis: an ongoing multicenter study . Presented at : 67th Annual Meeting of the American Academy of Neurology . Washington DC, USA, 18\u201325 April 2015 ."},{"key":"e_1_3_2_14_1","volume-title":"67th Annual Meeting of the American Academy of Neurology","author":"Foley J","year":"2015","unstructured":"Foley J , MetzgerR, HoytTet al. The effect of extended interval dosing and patient weight on long term natalizumab pharmacokinetics . Presented at : 67th Annual Meeting of the American Academy of Neurology . Washington DC, USA, 18\u201325 April 2015 ."},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2007.02.018"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.6810"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-015-0340-4"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000333780"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-32"}],"container-title":["Neurodegenerative Disease Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/nmt.15.42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:47:42Z","timestamp":1716493662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/nmt.15.42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.2217\/nmt.15.42"],"URL":"https:\/\/doi.org\/10.2217\/nmt.15.42","relation":{},"ISSN":["1758-2024","1758-2032"],"issn-type":[{"value":"1758-2024","type":"print"},{"value":"1758-2032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-10-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}